NFKB1 and colitis: Sulfasalazine ameliorates acute colitis in a mouse model induced by trinitrobenzene sulfonic acid, which involves the inhibition of NF-κB activation as well as the downregulation of NF-κB signaling components, such as TLR4, MyD88, and NF-κB RelA [427].